Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 11 matching records.
11 results — page 1 of 1
- Level DNarrative ReviewEurope PMC
Mesenchymal Stem Cells in Veterinary Medicine-Still Untapped Potential
Narrative Review on Osteoarthritis, Chronic Kidney Disease, Immune Modulation, published in Animals (Basel) (2025) — summary generated from the PubMed abstract.
- 2025
Animals (Basel)4 citations - Level CProspective StudyPubMed
Exploring the Tumor-Associated Risk of Mesenchymal Stem Cell Therapy in Veterinary Medicine.
Prospective Study, published in Animals (Basel) (2024) — summary generated from the PubMed abstract.
- 2024
Animals (Basel)3 citations - Level CCase Report / SeriesPubMed
Stone-induced urethral fistula treatment with microfragmented adipose tissue containing mesenchymal stem cells: a case report from veterinary medicine with potential application in humans.
Case Report / Series on Autoimmune Research, published in Croat Med J (2024) — summary generated from the PubMed abstract.
- 2024
Croat Med J - Level BClinical TrialPubMed
Intravenous injection of allogenic canine mesenchymal stem cells in 40 client-owned dogs: a safety assessment in veterinary clinical trials.
Clinical Trial on Systemic / IV, published in BMC Vet Res (2024) — summary generated from the PubMed abstract.
- 2024
BMC Vet Res - Level DAnimal StudyPubMed
Manufacturing and banking canine adipose-derived mesenchymal stem cells for veterinary clinical application.
Animal Study on Face & Skin, Systemic / IV, published in BMC Vet Res (2021) — summary generated from the PubMed abstract.
- 2021
BMC Vet Res13 citations - Level DNarrative ReviewPubMed
The Role of Mesenchymal Stem Cells (MSCs) in Veterinary Medicine and Their Use in Musculoskeletal Disorders.
Narrative Review, published in Biomolecules (2021) — summary generated from the PubMed abstract.
- 2021
Biomolecules22 citations - Level BClinical TrialEurope PMC
Veterinary Regenerative Medicine for Musculoskeletal Disorders: Can Mesenchymal Stem/Stromal Cells and Their Secretome Be the New Frontier?
Clinical Trial, published in Cells (2020) — summary generated from the PubMed abstract.
- 2020
Cells46 citations - Level DAnimal StudyPubMed
Systemic Administration of Rejuvenated Adipose-Derived Mesenchymal Stem Cells Improves Liver Metabolism in Equine Metabolic Syndrome (EMS)- New Approach in Veterinary Regenerative Medicine.
Animal Study on Type 2 Diabetes, published in Stem Cell Rev Rep (2019) — summary generated from the PubMed abstract.
- 2019
Stem Cell Rev Rep18 citations - Level DNarrative ReviewPubMed
Mesenchymal stem cell-based bone tissue engineering for veterinary practice.
Narrative Review, published in Heliyon (2019) — summary generated from the PubMed abstract.
- 2019
Heliyon21 citations - Level DNarrative ReviewPubMed
Current Status of Canine Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Veterinary Medicine.
Narrative Review on Scar, published in Stem Cells Int (2018) — summary generated from the PubMed abstract.
- 2018
Stem Cells Int - Level BClinical TrialPubMed
Adipose tissue derived mesenchymal stem cells for musculoskeletal repair in veterinary medicine.
Clinical Trial, published in Am J Stem Cells (2015) — summary generated from the PubMed abstract.
- 2015
Am J Stem Cells41 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406